166 related articles for article (PubMed ID: 27314680)
1. Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines.
Deng M; Wang J; Chen Y; Zhang L; Xie G; Liu Q; Zhang T; Yuan P; Liu D
Mol Med Rep; 2016 Aug; 14(2):1523-30. PubMed ID: 27314680
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
Wang H; Chen H; Zhou H; Yu W; Lu Z
Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
[TBL] [Abstract][Full Text] [Related]
3. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Cyclin-Dependent Kinase Inhibitor 3 Inhibits Proliferation and Invasion in Human Gastric Cancer Cells.
Li Y; Ji S; Fu LY; Jiang T; Wu D; Meng FD
Oncol Res; 2017 May; 25(5):721-731. PubMed ID: 27983933
[TBL] [Abstract][Full Text] [Related]
6. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
Deng X; Wu X; Weng H; Song F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1036-40. PubMed ID: 27412932
[TBL] [Abstract][Full Text] [Related]
7. The role of cyclin-dependent kinase inhibitor 3 in the proliferation and migration of renal cell carcinoma.
Ni C; Guo Z; Bu H; Zhao X; Bao M; Ding L; Liang C; Tang Q; Li J
Chem Biol Interact; 2024 Jul; 397():111092. PubMed ID: 38825053
[TBL] [Abstract][Full Text] [Related]
8. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
Dai W; Miao H; Fang S; Fang T; Chen N; Li M
Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic studies of cyclin-dependent kinase inhibitor 3 (CDKN3) in colorectal cancer.
Yang C; Sun JJ
Asian Pac J Cancer Prev; 2015; 16(3):965-70. PubMed ID: 25735390
[TBL] [Abstract][Full Text] [Related]
10. Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.
Qin B; Cheng K
Breast Cancer Res; 2010; 12(5):R74. PubMed ID: 20863366
[TBL] [Abstract][Full Text] [Related]
11. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis.
Deng X; Ma J; Zhou W; Yuan Y; Wang B; Meng X
Lab Invest; 2023 Jun; 103(6):100122. PubMed ID: 36828188
[TBL] [Abstract][Full Text] [Related]
12. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.
Barrón EV; Roman-Bassaure E; Sánchez-Sandoval AL; Espinosa AM; Guardado-Estrada M; Medina I; Juárez E; Alfaro A; Bermúdez M; Zamora R; García-Ruiz C; Gomora JC; Kofman S; Pérez-Armendariz EM; Berumen J
PLoS One; 2015; 10(9):e0137397. PubMed ID: 26372210
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.
Xing C; Xie H; Zhou L; Zhou W; Zhang W; Ding S; Wei B; Yu X; Su R; Zheng S
Biochem Biophys Res Commun; 2012 Mar; 420(1):29-35. PubMed ID: 22390936
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.
Xie SL; Zhu MG; Chen GF; Wang GY; Lv GY
Mol Med Rep; 2015 Oct; 12(4):5077-85. PubMed ID: 26165487
[TBL] [Abstract][Full Text] [Related]
15. YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.
Liu D; Zhang J; Wu Y; Shi G; Yuan H; Lu Z; Zhu Q; Wu P; Lu C; Guo F; Chen J; Jiang K; Miao Y
Int J Cancer; 2018 Apr; 142(7):1392-1404. PubMed ID: 29168185
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.
Yu C; Cao H; He X; Sun P; Feng Y; Chen L; Gong H
Biomed Pharmacother; 2017 Dec; 96():1109-1118. PubMed ID: 29196103
[TBL] [Abstract][Full Text] [Related]
17. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
[TBL] [Abstract][Full Text] [Related]
18. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
19. Targeting CDKN3 in cervical cancer.
Berumen J; Espinosa AM; Medina I
Expert Opin Ther Targets; 2014 Oct; 18(10):1149-62. PubMed ID: 25152075
[TBL] [Abstract][Full Text] [Related]
20. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
